MyFinsight
Home
Compare
Blog
About
Proceeds from initial
public offering, net of...
$239,338K
Proceeds from exercise of
stock options
$807K
Net cash provided by
financing activities
$240,928K
Effect of exchange
rates on cash and cash...
$29K
Net increase
(decrease) in cash and cash...
$11,314K
Canceled cashflow
$229,643K
Proceeds from maturities
of investments
$50,000K
Stock-based compensation
expense
$36,863K
Accrued expenses and
other current...
$1,038K
Accounts payable
$910K
Amortization of operating
lease right-of-use...
$325K
Depreciation expense
$26K
Net cash used in
investing activities
-$203,502K
Net cash used in
operating activities
-$26,141K
Canceled cashflow
$50,000K
Canceled cashflow
$39,162K
Purchase of investments
$253,502K
Net loss
-$62,600K
Prepaid expenses and
other current assets
$2,004K
Net amortization of
premium and discounts on...
-$359K
Operating lease liability
-$329K
Related party payable
-$11K
Back
Back
Cash Flow
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX)
source: myfinsight.com